Medpace
MEDP
602 hedge funds and large institutions have $8.28B invested in Medpace in 2025 Q2 according to their latest regulatory filings, with 75 funds opening new positions, 226 increasing their positions, 226 reducing their positions, and 54 closing their positions.
39% more first-time investments, than exits
New positions opened: 75 | Existing positions closed: 54
7.83% more ownership
Funds ownership: 83.91% → 91.74% (+7.8%)
6% more capital invested
Capital invested by funds: $7.78B → $8.28B (+$499M)
3% more funds holding
Funds holding: 586 → 602 (+16)
0% more repeat investments, than reductions
Existing positions increased: 226 | Existing positions reduced: 226
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
49% less call options, than puts
Call options by funds: $17.1M | Put options by funds: $33.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$156M |
| 2 |
MAM
Madison Asset Management
Madison,
Wisconsin
|
+$86.3M |
| 3 |
Jane Street
New York
|
+$80.7M |
| 4 |
Millennium Management
New York
|
+$75.7M |
| 5 |
Morgan Stanley
New York
|
+$56.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$221M |
| 2 |
BlackRock
New York
|
-$67.1M |
| 3 |
Goldman Sachs
New York
|
-$55.4M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$42.9M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$41.8M |
MEDP Hedge Fund Activity: Q2 2025 in Review
602 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q2 2025, worth a combined $8.28B — up 6.4% from $7.78B a quarter earlier.
Buyers outnumbered sellers: 75 funds opened new MEDP positions and 54 closed out — a net gain of 21 holders — while 226 added to existing stakes and 226 trimmed.
The largest buyer was Baillie Gifford & Co, adding an estimated $156M. The largest seller was Invesco, cutting an estimated $221M.
- 602 institutional investors held Medpace (MEDP) as of Q2 2025, up from 586 in Q1 2025.
- Funds reported $8.28B of Medpace stock for Q2 2025, up 6.4% quarter-over-quarter.
- 75 funds opened new Medpace positions in Q2 2025 and 54 closed out, a net change of +21 holders.
- The largest Medpace buyer in Q2 2025 was Baillie Gifford & Co, an estimated $156M added.
- The largest Medpace seller in Q2 2025 was Invesco, an estimated $221M sold.
Based on aggregated 13F filings for Q2 2025.